9999999997-15-014565.txt : 20151112 9999999997-15-014565.hdr.sgml : 20151112 20151112163431 ACCESSION NUMBER: 9999999997-15-014565 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151112 DATE AS OF CHANGE: 20151112 20151112 20151112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-183384 FILM NUMBER: 151225299 BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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